CWIG
UTHR icon

Chung Wu Investment Group’s United Therapeutics UTHR Stock Holding History

Chung Wu Investment Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Hold
50
– – 0.02% 186
2026
Q1 		$29.6K Sell
50
-50
-50% -$24.9K 0.03% 154
2025
Q4 		$48.7K Hold
100
– – 0.04% 137
2025
Q3 		$41.9K Hold
100
– – 0.03% 144
2025
Q2 		$28.7K Buy
+100
New +$29.9K 0.03% 151

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Chung Wu Investment Group's UTHR Position: Q2 2026 in Review

Chung Wu Investment Group held its United Therapeutics (UTHR) position steady in Q2 2026 at 50 shares worth $27.1K. The position accounts for 0.02% of the portfolio, ranked #186.

Chung Wu Investment Group first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $48.7K in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Chung Wu Investment Group held 50 shares of United Therapeutics worth $27.1K as of Q2 2026.
  • Chung Wu Investment Group left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.02% of Chung Wu Investment Group's portfolio in Q2 2026, its #186 holding.
  • Chung Wu Investment Group first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Chung Wu Investment Group's United Therapeutics position peaked at $48.7K in Q4 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Chung Wu Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.